GEN Edge spoke with Simon Harnest, Metagenomi’s CIO and SVP of Strategy, to discusses the company’s strategy to become a leading force in genome editing . . .
See More on the Edge
Continue reading this article and more
with a GEN Edge subscription
The post The Meta(nuclease)verse: Metagenomi Is Developing the Next Generation of Gene-Editing Therapies appeared first on GEN – Genetic Engineering and Biotechnology News.
